Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eli-Lilly
Company Monitoring Page for Eli-Lilly
latest headlines for company on cafepharma
Look here, FDA: Eli Lilly touts Olumiant safety data for unapproved high dose
Fierce Pharma
Wed, 06/12/19 - 06:43 pm
Tags:
Eli Lilly
,
Incyte
,
olumiant
,
safety data
,
Humira
,
rheumatoid arthritis
Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales
Fierce Pharma
Tue, 06/11/19 - 06:00 pm
Tags:
Eli Lilly
,
Taltz
,
psoriasis
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Tue, 06/11/19 - 12:06 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
ADA
,
diabetes
,
Tradjenta
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Fierce Biotech
Mon, 06/10/19 - 09:39 am
Tags:
Eli Lilly
,
NASH
,
tirzepatide
,
clinial trials
,
ADA
,
type 2 diabetes
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Mon, 06/10/19 - 09:27 am
Tags:
Eli Lilly
,
ADA
,
diabetes
,
heart attack
,
stroke
,
Trulicity
,
Novo Nordisk
,
semaglutide
Eli Lilly throws SCOTUS hail mary in Cialis patent infringement fight
Fierce Pharma
Fri, 06/7/19 - 12:04 pm
Tags:
Eli Lilly
,
Cialis
,
patents
,
Patent Infringement
,
benign prostatic hyperplasia
,
Supreme Court
Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction
TheStreet.com
Thu, 06/6/19 - 09:36 am
Tags:
Eli Lilly
,
Emgality
,
cluster headaches
Lilly's scored its cluster headache nod for Emgality. Will it shake up the CGRP race?
Fierce Pharma
Wed, 06/5/19 - 12:04 am
Tags:
Eli Lilly
,
Emgality
,
cluster headaches
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Fierce Pharma
Wed, 06/5/19 - 12:03 am
Tags:
China
,
Sanofi
,
Eli Lilly
,
Bristol-Myers Squibb
June 3 ASCO Quick Takes: ORR of 32% for Celgene's iberdomide in MM; plus Five Prime, Iovance and more
BioCentury
Mon, 06/3/19 - 08:17 pm
Tags:
ASCO 2019
,
Celgene
,
Multiple Myeloma
,
Five Prime Therapeutics
,
Iovance
,
Merck
,
Moderna Therapeutics
,
Eli Lilly
,
ICR
ASCO data for Blueprint's BLU-667 competitive with Lilly's LOXO-292 in RET-altered cancers
BioCentury
Mon, 06/3/19 - 11:25 am
Tags:
Blueprint Medicines
,
BLU-667
,
ASCO 2019
,
Eli Lilly
,
RET-altered cancer
,
LOXO-292
A bruised Eli Lilly buys rights to Centrexion’s early-stage pain drug for $47.5M upfront
Endpoints
Tue, 05/28/19 - 10:09 am
Tags:
Eli Lilly
,
non-opioid pain treatments
,
Centrexion
,
CNTX-0290
Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart
BioSpace
Thu, 05/23/19 - 12:28 pm
Tags:
Eli Lilly
,
drug pricing
,
generics
,
insulin
,
diabetes
,
Lispro
,
KwikPens
Lilly’s Mirikizumab succeeds in phase 2 study in Crohn’s disease
Pharmaceutical Business Review
Wed, 05/22/19 - 09:55 am
Tags:
Eli Lilly
,
Crohn's Disease
,
mirikizumab
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 05/19/19 - 03:59 pm
Tags:
Incyte
,
Novartis
,
Athersys
,
ResTORbio
,
Bellerophon Therapeutics
,
Eli Lilly
,
CymaBay
,
Bicycle Therapeutics
,
Peloton Therapeutics
,
Ideaya
,
IPOs
3 Top Diabetes Stocks to Watch in May
Motley Fool
Wed, 05/15/19 - 10:29 am
Tags:
diabetes
,
AstraZeneca
,
Eli Lilly
,
Medtronic
How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says
Fierce Pharma
Tue, 05/14/19 - 04:55 pm
Tags:
Teva Pharmaceutical
,
migraines
,
Ajovy
,
Amgen
,
Eli Lilly
,
Emgality
,
Aimovig
,
neurologists
,
physicians
,
DTC advertising
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Tue, 05/14/19 - 09:56 am
Tags:
Alzheimer's disease
,
drug development
,
aducanumab
,
Biogen
,
Eisai
,
BAN2401
,
Merck
,
Eli Lilly
,
AstraZeneca
Lilly gets fifth use for Cyramza with FDA liver cancer nod
Pharmaforum
Mon, 05/13/19 - 10:07 am
Tags:
Eli Lilly
,
Cyramza
,
FDA
,
liver cancer
,
hepatocellular carcinoma
Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions
Yahoo/Reuters
Sat, 05/11/19 - 12:10 pm
Tags:
Eli Lilly
,
Amgen
,
Teva Pharmaceutical
,
migraines
,
Emgality
,
Aimovig
Pages
« first
‹ previous
…
47
48
49
50
51
52
53
54
55
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.